A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/00 (2006.01) A61K 38/50 (2006.01)
Patent
CA 2346063
Method of inhibiting or treating Human Immunodeficiency Virus (HIV) infection, comprising administering to a patient in need thereof an effective amount of a pharmaceutically acceptable composition comprising a PEG-ASNase compound or asparaginase, and optionally at least one compound selected from the group consisting of protease inhibitor compounds, ribonucleotide reductase inhibitor compounds and HIV reverse transcriptase inhibitor compounds.
La présente invention concerne un procédé d'inhibition ou de traitement de l'infection par le Virus d'Immunodéficience Humaine (VIH), comprenant l'administration à un patient qui en a besoin d'une quantité efficace d'un point de vue thérapeutique d'asparaginase ou de l'un de ses sels pharmaceutiquement acceptables, et éventuellement d'au moins un composé choisi parmi le groupe comprenant les composés inhibiteurs de protéase, les composés inhibiteurs de ribonucléotide réductase et les composés inhibiteurs de transcriptase inverse du VIH ou l'un de leurs sels pharmaceutiquement acceptables.
Avramis Vassilios L.
Cohen Lewis
Aventis Pharmaceuticals Products Inc.
Enzon Pharmaceuticals Inc.
Goudreau Gage Dubuc
LandOfFree
Composition and methods for treatment of hiv infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and methods for treatment of hiv infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and methods for treatment of hiv infection will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1995832